Expression vectors comprising the mcmv ie2 promoter
CA 2516157 C · Owner: Merck Serono Sa · Inventors: Chatellard, Philippe; Imhof, Markus
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to an expression vector comprising the promoter of the mCMV-IE2 gene, or a functional expression promoting fragment thereof and/or , an enhancer of the mCMV-IE2 gene or a functional expression enhancing , fragment thereof wherein the expression vector does not contain any complete gene of the mCMV.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 10, 2004 and granted September 18, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 10, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 10, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.